Company profile

CHEMED CORP

NYSE:CHEMedical/Nursing Services

Drug pipeline (1)

AssetStageRevenueTrialsStatus
HEXACHLOROPHENEapproved0

Revenue is the latest reported period from SEC filings. A combination product's amount appears on each of its constituent assets, so those rows are not additive.

Clinical trials (0)

No records yet.

FDA applications (2)

ApplicationTypeApplicantProducts
NDA 017423NDAVESTAL LABORATORIES DIV CHEMED CORP
NDA 017424NDAVESTAL LABORATORIES DIV CHEMED CORP